Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide plus whey protein supplementation for body composition in adults with overweight or obesity
RBR-2p5tjv6Phase 2Not yet recruiting
- Sponsor
- GAP Saúde
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tirzepatide in obesity and Overweight (2 arms), sponsored by GAP Saúde. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on RBR-2p5tjv6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2p5tjv6.